Familial Pituitary Adenomas — Who Should be Tested for AIP Mutations?

Márta Korbonits; Helen Storr; Ajith V. Kumar


Clin Endocrinol. 2012;77(3):351-356. 

In This Article


The prevalence of symptomatic pituitary tumours in the general population is estimated to be in the region of 1 in a 1000 to 1 in 1400.[33–36] Autopsy and radiological studies indicate that 14–22% of the population may harbour a pituitary tumour, most of these being asymptomatic.[37] Therefore, it is possible for more than one pituitary tumour to occur within a family by chance. Instances of phenocopies in families with an AIP mutation have already been documented.[9,13] Phenocopies will probably also be identified in AIP mutation–negative families as well, when the causative gene(s) are identified.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.
Post as: